Oral glycine administration increases brain glycine/creatine ratios in men: A proton magnetic resonance spectroscopy study

Aprison, 1969, A comparison of the concentration of glycine, a transmitter suspect, in different areas of the brain and spinal cord in seven different vertebrates, Comparative Biochemistry and Physiology, 28, 1345, 10.1016/0010-406X(69)90571-4 Backstrom, 2006, Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking, Neuropsychopharmacology, 31, 778, 10.1038/sj.npp.1300845 Behar, 1994, Analysis of macromolecule resonances in 1H NMR spectra of human brain, Magnetic Resonance in Medicine, 32, 294, 10.1002/mrm.1910320304 Bergeron, 1998, Modulation of N-methyl-D-aspartate receptor function by glycine transport, Proceedings of the National Academy of Sciences of the United States of America, 95, 15730, 10.1073/pnas.95.26.15730 Billups, 2003, Active release of glycine or D-serine saturates the glycine site of NMDA receptors at the cerebellar mossy fibre to granule cell synapse, European Journal of Neuroscience, 18, 2975, 10.1111/j.1460-9568.2003.02996.x Bisaga, 2000, In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists, Drug and Alcohol Dependence, 59, 1, 10.1016/S0376-8716(99)00107-6 Boulay, 2008, Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia, Pharmacology, Biochemistry and Behavior, 91, 47, 10.1016/j.pbb.2008.06.009 Buchanan, 2007, The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments, American Journal of Psychiatry, 164, 1593, 10.1176/appi.ajp.2007.06081358 Choi, 2008, Measurement of glycine in human brain by triple refocusing 1H-MRS in vivo at 3.0T, Magnetic Resonance in Medicine, 59, 59, 10.1002/mrm.21450 Costa, 1990, An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics, Journal of Clinical Psychopharmacology, 10, 71, 10.1097/00004714-199002000-00027 Coyle, 2006, Substance use disorders and schizophrenia: a question of shared glutamatergic mechanisms, Neurotoxicity Research, 10, 221, 10.1007/BF03033359 Depoortere, 2005, Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic, Neuropsychopharmacology, 30, 1963, 10.1038/sj.npp.1300772 Dopico, 2006, Glycine release in the substantia nigra: interaction with glutamate and GABA, Neuropharmacology, 50, 548, 10.1016/j.neuropharm.2005.10.014 D'Souza, 2000, IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans, Biological Psychiatry, 47, 450, 10.1016/S0006-3223(99)00133-X Evins, 2000, Placebo-controlled trial of glycine added to clozapine in schizophrenia, American Journal of Psychiatry, 157, 826, 10.1176/appi.ajp.157.5.826 Flogel, 1995, Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: a multinuclear NMR study, Neurochemical Research, 20, 793, 10.1007/BF00969691 Galli, 1993, Sodium-dependent release of exogenous glycine from preloaded rat hippocampal synaptosomes, Journal of Neural Transmission. General Section, 93, 167, 10.1007/BF01244994 Goff, 1996, D-cycloserine added to clozapine for patients with schizophrenia, American Journal of Psychiatry, 153, 1628, 10.1176/ajp.153.12.1628 Govindaraju, 2000, Proton NMR chemical shifts and coupling constants for brain metabolites, NMR in Biomedicine, 13, 129, 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V Gozzi, 2008, Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat, Psychopharmacology (Berlin), 201, 273, 10.1007/s00213-008-1271-z Gundlach, 1982, Neurochemical studies of the mesolimbic dopaminergic pathway: glycinergic mechanisms and glycinergic-dopaminergic interactions in the rat ventral tegmentum, Journal of Neurochemistry, 38, 574, 10.1111/j.1471-4159.1982.tb08665.x Harsing, 2001, The role of glycineB binding site and glycine transporter (GlyT1) in the regulation of [3H]GABA and [3H]glycine release in the rat brain, Neurochemical Research, 26, 915, 10.1023/A:1012328300037 Hashimoto, 2008, Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine, European Neuropsychopharmacology, 18, 414, 10.1016/j.euroneuro.2007.07.009 Hayashi, 2006, Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors, Glia, 53, 660, 10.1002/glia.20322 Hejazi, 2006, Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors, Molecular Pharmacology, 69, 991, 10.1124/mol.105.019174 Hejnum, 2007, High-affinity glycine and glutamate transport in pig forebrain white and gray matter: a quantitative study, Neurochemistry International, 50, 696, 10.1016/j.neuint.2007.01.002 Heresco-Levy, 1996, Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia, British Journal of Psychiatry, 169, 610, 10.1192/bjp.169.5.610 Heresco-Levy, 1999, Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia, Archives of General Psychiatry, 56, 29, 10.1001/archpsyc.56.1.29 Heresco-Levy, 2004, High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia, Biological Psychiatry, 55, 165, 10.1016/S0006-3223(03)00707-8 Huang, 2004, Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices, Journal of Physiology, 560, 721, 10.1113/jphysiol.2004.067801 Hurd, 2004, Measurement of brain glutamate using TE-averaged PRESS at 3T, Magnetic Resonance in Medicine, 51, 435, 10.1002/mrm.20007 Javitt, 1991, Recent advances in the phencyclidine model of schizophrenia, American Journal of Psychiatry, 148, 1301, 10.1176/ajp.148.10.1301 Javitt, 1994, Amelioration of negative symptoms in schizophrenia by glycine, American Journal of Psychiatry, 151, 1234, 10.1176/ajp.151.8.1234 Javitt, 2001, Adjunctive high-dose glycine in the treatment of schizophrenia, International Journal of Neuropsychopharmacology, 4, 385, 10.1017/S1461145701002590 Javitt, 2005, Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action, Molecular Psychiatry, 10, 276, 10.1038/sj.mp.4001552 Johnson, 1987, Glycine potentiates the NMDA response in cultured mouse brain neurons, Nature, 325, 529, 10.1038/325529a0 Kanahara, 2008, Glycine and D:-serine, but not D:-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801, Psychopharmacology (Berlin), 198, 363, 10.1007/s00213-008-1151-6 Karasawa, 2008, D-serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats, Behavioural Brain Research, 186, 78, 10.1016/j.bbr.2007.07.033 Kaufman, 2003, Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study, Biological Psychiatry, 54, 534, 10.1016/S0006-3223(02)01828-0 Kessler, 1989, A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists, Journal of Neurochemistry, 52, 1319, 10.1111/j.1471-4159.1989.tb01881.x Kleckner, 1988, Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes, Science, 241, 835, 10.1126/science.2841759 Konradsson, 2006, Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex, Synapse, 60, 102, 10.1002/syn.20286 Labrie, 2008, Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia, Psychopharmacology (Berlin), 200, 217, 10.1007/s00213-008-1196-6 Lane, 2005, Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study, Archives of General Psychiatry, 62, 1196, 10.1001/archpsyc.62.11.1196 Leiderman, 1996, Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial, Biological Psychiatry, 39, 213, 10.1016/0006-3223(95)00585-4 Linn, 2007, Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine, Psychopharmacology (Berlin), 192, 27, 10.1007/s00213-007-0771-6 Martin, 2004, Chronic morphine treatment alters N-methyl-D-aspartate receptors in freshly isolated neurons from nucleus accumbens, Journal of Pharmacology and Experimental Therapeutics, 311, 265, 10.1124/jpet.104.067504 Neumeister, 2006, Cerebral metabolic effects of intravenous glycine in healthy human subjects, Journal of Clinical Psychopharmacology, 26, 595, 10.1097/01.jcp.0000245558.14284.aa Ogg, 1994, WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy, Journal of Magnetic Resonance B, 104, 1, 10.1006/jmrb.1994.1048 Olney, 1995, Glutamate receptor dysfunction and schizophrenia, Archives of General Psychiatry, 52, 998, 10.1001/archpsyc.1995.03950240016004 Potkin, 1999, Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia, American Journal of Psychiatry, 156, 145, 10.1176/ajp.156.1.145 Prescot, 2006, In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T, Magnetic Resonance in Medicine, 55, 681, 10.1002/mrm.20807 Provencher, 1993, Estimation of metabolite concentrations from localized in vivo proton NMR spectra, Magnetic Resonance in Medicine, 30, 672, 10.1002/mrm.1910300604 Provencher, 2005, 163 Roberto, 2004, Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis, Journal of Neuroscience, 24, 1594, 10.1523/JNEUROSCI.5077-03.2004 Rosse, 1989, Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study, Clinical Neuropharmacology, 12, 416, 10.1097/00002826-198910000-00006 Roux, 2000, Neuronal and glial glycine transporters have different stoichiometries, Neuron, 25, 373, 10.1016/S0896-6273(00)80901-0 Silk, 1974, Amino acid and peptide absorption in patients with coeliac disease and dermatitis herpetiformis, Gut, 15, 1, 10.1136/gut.15.1.1 Stoll, 1998, Catabolism dominates the first-pass intestinal metabolism of dietary essential amino acids in milk protein-fed piglets, Journal of Nutrition, 128, 606, 10.1093/jn/128.3.606 Toth, 1981, Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses, Neurochemical Research, 6, 1309, 10.1007/BF00964352 Toth, 1986, Antagonism of phencyclidine-induced hyperactivity by glycine in mice, Neurochemical Research, 11, 393, 10.1007/BF00965013 Tsai, 1999, D-serine added to clozapine for the treatment of schizophrenia, American Journal of Psychiatry, 156, 1822, 10.1176/ajp.156.11.1822 Urenjak, 1993, Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types, Journal of Neuroscience, 13, 981, 10.1523/JNEUROSCI.13-03-00981.1993 Vengeliene, 2005, The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect, Neuropharmacology, 48, 822, 10.1016/j.neuropharm.2005.01.002 Viola, 2002, Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia, Pediatric Research, 52, 292, 10.1203/00006450-200208000-00024 Waziri, 1988, Glycine therapy of schizophrenia, Biological Psychiatry, 23, 210, 10.1016/0006-3223(88)90093-5 Williams, 2004, Effects of typical and atypical antipsychotics on human glycine transporters, Schizophrenia Research, 71, 103, 10.1016/j.schres.2004.01.013 Wojcik, 2006, A shared vesicular carrier allows synaptic corelease of GABA and glycine, Neuron, 50, 575, 10.1016/j.neuron.2006.04.016 Wu, 1998, Intestinal mucosal amino acid catabolism, Journal of Nutrition, 128, 1249, 10.1093/jn/128.8.1249 Zafra, 1995, Glycine transporters are differentially expressed among CNS cells, Journal of Neuroscience, 15, 3952, 10.1523/JNEUROSCI.15-05-03952.1995